Medication info
Wont Transemi Sustained-Release Tablet

Wont Transemi Sustained-Release Tablet

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›37.5mg / 1 tabletAcetaminophen›162.5mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
Pale yellow round film-coated sustained-release tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201307896 · Approved 2013.06.27 · Insurance code 671805560

Summary

Main use
Relieves moderate to severe acute and chronic pain
Who takes it
Adults
Adult dose
Adults: The dose should be adjusted according to the patient's degree of pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 12 hours, and no more than 8 tablets should be taken per day. Do not use this medication for longer than necessary. If prolonged administration is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medication should be continued. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur when taking this medication; therefore, closely monitor the patient's response and adjust treatment appropriately. Older adults: Administer the usual adult dose. However, when tramadol is administered orally to older adults aged 75 years or older, the elimination half-life of tramadol increases by 17%; therefore, administer this medication at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medication in patients with renal impairment have not been established; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medication in patients with hepatic impairment have not been established; therefore, its use is not recommended.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Relieves moderate to severe acute and chronic pain

  • Acute pain
  • chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the patient's degree of pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 12 hours, and no more than 8 tablets should be taken per day. Do not use this medication for longer than necessary. If prolonged administration is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medication should be continued. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur when taking this medication; therefore, closely monitor the patient's response and adjust treatment appropriately. Older adults: Administer the usual adult dose. However, when tramadol is administered orally to older adults aged 75 years or older, the elimination half-life of tramadol increases by 17%; therefore, administer this medication at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medication in patients with renal impairment have not been established; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medication in patients with hepatic impairment have not been established; therefore, its use is not recommended.

Precautions

This medication may put stress on the liver; therefore, those who regularly consume more than three drinks a day must consult a doctor or pharmacist before taking it. If severe rashes or allergic reactions such as hives occur during the course of taking this medication, stop taking it immediately and inform medical personnel. One of the ingredients in this medication, tramadol, may increase the risk of seizures; therefore, patients with a history of seizures or those at risk for seizures should take it with caution. Taking tramadol with certain antidepressants or other central nervous system depressants may increase the risk of seizures or serious side effects, so consult a physician. In patients with severe respiratory diseases, this medication may suppress breathing, and should be administered in a monitored environment if necessary. Caution is required when taking this medication in conjunction with alcohol or benzodiazepine medications, as it may lead to severe drowsiness, respiratory depression, or coma. Patients with head injuries or elevated intracranial pressure should take this medication cautiously, as symptoms may worsen. This medication can cause physical and psychological dependence; therefore, long-term use should be carefully monitored for dependence and abuse risks. Patients with impaired liver function may face a risk of liver damage when taking this medication, so they must consult healthcare providers before taking it. Particularly, patients genetically predisposed to rapid metabolism of this medication may have an increased risk of side effects like respiratory depression, thus requiring dose adjustment and close monitoring. This medication should not be administered to children under 12 years old or adolescents under 18 years old who have undergone tonsillectomy and adenoidectomy. Elderly patients or those with decreased kidney or liver function may have an increased risk of side effects from this medication, so caution is advised. Pregnant or breastfeeding women should consult a physician before taking this medication, particularly during breastfeeding, as it may transfer to breast milk and pose risks to the baby. This medication may cause drowsiness or dizziness, so caution is needed when driving or operating machinery. In case of overdose, serious respiratory depression or liver damage may occur, so prescribed dosages must be adhered to, and immediate emergency measures should be taken in case of overdose. Abruptly stopping this medication may cause withdrawal symptoms, so it should be gradually reduced under medical supervision when discontinuing.

Side effects

Liver damage, acute generalized rash-like pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, weakness, fatigue, flushing, chest pain, rigidity, syncope, withdrawal symptoms, hypertension, worsening hypertension, hypotension, arrhythmia, palpitations, tachycardia, dizziness, headache, tremors, ataxia, spasms, hypertonia, migraine, exacerbation of migraine, involuntary muscle contractions, paresthesia, confusion, dizziness, abdominal pain, constipation, diarrhea, indigestion, flatulence, dry mouth, nausea, vomiting, dysphagia, bloody stools, tongue swelling, decreased appetite, anxiety, delirium, euphoria, insomnia, neuroticism, drowsiness, forgetfulness, depersonalization, depression, substance abuse, dependence, emotional instability, hallucinations, erectile dysfunction, nightmares, abnormal thoughts, anemia, dyspnea, proteinuria, urination disorder, oliguria, urine retention, pruritus, rash, sweating, urticaria, abnormal liver function, weight loss, tinnitus, abnormal vision, chills, vasodilation, orthostatic hypotension, bradycardia, collapse, myocardial ischemia, pulmonary edema, bronchospasm, wheezing, angioedema, allergic reactions, anaphylaxis, Stevens-Johnson syndrome, change in appetite, muscle weakness, respiratory depression, cognitive dysfunction, difficulty concentrating, suicidal tendencies, hepatitis, liver failure, gastrointestinal bleeding, psychiatric side effects, prolonged prothrombin time, serotonin syndrome, exacerbation of asthma, withdrawal symptoms, delirium, miosis, mydriasis, speech disorders, movement disorders, hypoglycemia, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, allergic reactions, thrombocytopenia, agranulocytosis, hypoprothrombinemia, pyruvate carboxylase deficiency, weakness, fever, edema, rigidity, syncope, congestive heart failure, dizziness, confusion, exercise-induced dyspnea, bronchitis, urine positive for red blood cells, increased blood pressure, palpitations, irregular menstrual cycles, breast cancer, injury, confusion, migraine, speech disorders, loss of consciousness, recurrent myocardial infarction, hypotension, confusion, multiple organ failure, intentional overdose, memory impairment, lack of efficacy, facial flushing, chest burning, unspecified gastrointestinal distress, acute gastritis, cold, upper respiratory infection, systemic weakness, motion sickness, transient ischemic attack, lethargy, bleeding, elevated cholesterol, hip pain, thigh pain, allergic rhinitis, epistaxis, cholangiocarcinoma progression, foreign body sensation in the eye, liver cancer progression, paralyzing gastrointestinal obstruction, cholecystitis, abnormal kidney function tests, increased salivation, drowsiness, insomnia, neuroticism, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, thrombocytopenia, palpitations, hypertension, arrhythmia, tachycardia, worsening hypertension, aortic stenosis, nausea, vomiting, indigestion, abdominal pain, constipation, dry mouth, diarrhea, dysphagia, flatulence, tongue swelling, increased salivation, rectal cancer progression, esophageal cancer progression, stomach cancer progression, hiccups, cholecystitis, drowsiness, insomnia, decreased appetite, anxiety, depression, neuroticism, emotional instability, hallucinations, depersonalization, dyspnea, asthma, exercise-induced dyspnea, cough, bronchitis, urination disorder, urine retention, frequent urination, abnormal kidney function tests, oliguria, pruritus, rash, increased sweating, urticaria, itching, hyperhidrosis, urticaria, rash, cold sweat, blood pressure fluctuations, pallor, cough, runny nose, nausea, constipation, vomiting, indigestion, discomfort in the chest, facial swelling, chills, fever, peripheral edema, weakness, vasodilation, orthostatic hypotension, bradycardia, collapse, myocardial ischemia, pulmonary edema, respiratory symptoms, allergic reactions, anaphylaxis, urticaria, Stevens-Johnson syndrome, withdrawal symptoms, delirium, miosis, mydriasis, speech disorders, movement disorders, hypoglycemia, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, thrombocytopenia, agranulocytosis, hypoprothrombinemia, pyruvate carboxylase deficiency, withdrawal symptoms, panic attacks, severe anxiety, hallucinations, paresthesia, tinnitus, abnormal central nervous system reactions, urticaria, rash, bronchial spasms, toxic skin necrosis, Stevens-Johnson syndrome, spasms, serotonin syndrome, withdrawal symptoms, hepatotoxicity, abnormal liver function, paralyzing gastrointestinal obstruction, cholecystitis, confusion, drowsiness, insomnia, anxiety, hallucinations, paresthesia, tinnitus, abnormal central nervous system reactions, withdrawal symptoms, respiratory depression, somnolence, coma, cardiac arrest, QT prolongation, hepatic failure, renal tubular necrosis, hypoglycemia, coagulopathy, anxiety, sweating, insomnia, rigidity, pain, nausea, tremors, diarrhea, upper respiratory syndrome, hiccups, excitement, neuroticism, hyperactivity, acute or chronic adrenal insufficiency, severe abdominal pain, hypotension, extreme fatigue, decreased appetite, weight loss, opioid-induced hyperalgesia, withdrawal syndrome, respiratory depression, life-threatening respiratory depression, death

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. It is recommended to maintain storage temperatures between 1 degree Celsius and 30 degrees Celsius.

Appearance and packaging

Appearance

Pale yellow round film-coated sustained-release tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.